MODULATION OF DIPYRIDAMOLE ACTION BY ALPHA-1-ACID GLYCOPROTEIN - REDUCED POTENTIATION OF QUINAZOLINE ANTIFOLATE (CB3717) CYTO-TOXICITY BY DIPYRIDAMOLE

被引：17

作者：

CURTIN, NJ ^{[1
]}

NEWELL, DR ^{[1
]}

HARRIS, AL ^{[1
]}

机构：

[1] INST CANC RES, DRUG DEV SECT, SUTTON SM2 5NG, SURREY, ENGLAND

来源：

BIOCHEMICAL PHARMACOLOGY | 1989年 / 38卷 / 19期

关键词：

D O I：

10.1016/0006-2952(89)90626-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：3281 / 3288

页数：8

共 51 条

[1]

BELT JA, 1985, P AM ASSOC CANC RES, V26, P264

[2]

CHAN TCK, 1985, CANCER TREAT REP, V69, P425

[3]

CHAN TCK, 1985, CANCER RES, V45, P3598

[4]

CHAN TCK, 1986, CANCER RES, V46, P3168

[5]

Cooper E H, 1979, Adv Cancer Res, V30, P1, DOI 10.1016/S0065-230X(08)60893-3

[6] INHIBITION OF PLATELET-AGGREGATION BY NATIVE AND DESIALIZED ALPHA-1 ACID GLYCOPROTEIN [J].

COSTELLO, M ;

FIEDEL, BA ;

GEWURZ, H .

NATURE, 1979, 281 (5733) :677-678

[7] POTENTIATION OF QUINAZOLINE ANTIFOLATE (CB3717) TOXICITY BY DIPYRIDAMOLE IN HUMAN-LUNG CARCINOMA, A549, CELLS [J].

CURTIN, NJ ;

HARRIS, AL .

BIOCHEMICAL PHARMACOLOGY, 1988, 37 (11) :2113-2120

[8] ROLE OF ADENOSINE UPTAKE AND METABOLISM BY BLOOD-CELLS IN THE ANTIPLATELET ACTIONS OF DIPYRIDAMOLE, DILAZEP AND NITROBENZYLTHIOINOSINE [J].

DAWICKI, DD ;

AGARWAL, KC ;

PARKS, RE .

BIOCHEMICAL PHARMACOLOGY, 1985, 34 (22) :3965-3972

[9] PHARMACOKINETICS OF ORAL DIPYRIDAMOLE (PERSANTINE) AND ITS EFFECT ON PLATELET ADENOSINE UPTAKE IN MAN [J].

DRESSE, A ;

CHEVOLET, C ;

DELAPIERRE, D ;

MASSET, H ;

WEISENBERGER, H ;

BOZLER, G ;

HEINZEL, G .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 23 (03) :229-234

[10] OPTICAL STUDIES ON THE SPECIFIC INTERACTION OF DIPYRIDAMOLE WITH ALPHA-1-ACID GLYCOPROTEIN (OROSOMUCOID) [J].

ELGAMEL, S ;

WOLLERT, U ;

MULLER, WE .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (03) :152-157

← 1 2 3 4 5 6 →